Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Criteo S.A.CRTO · Entity 291 | Director | November 08, 2018 | November 13, 2018 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Criteo S.A.
Report date November 08, 2018 · Filed November 13, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Non-employee Warrant (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $22.45 · Expires 2028-10-25 | Direct | 25,000 |
Reported balance
After 2018-11-08 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2018-11-08 · Grant · Acquired 25,000 · Balance 25,000 F1: The exercise price of the non-employee warrant is 19.71 Euros. The U.S. dollar equivalent of the exercise price is $22.45 using the European Central Bank rate as of October 24, 2018 (1.00 = $1.1389), the date that is one business day prior to the date on which the issuer's board of directors determined the exercise price of the non-employee warrants. F4: The subscription price of the non-employee warrant is $7.87. The subscription price was satisfied by offset from fees otherwise paid to the reporting person by the issuer for service as a director. F2: One-fourth of the grant will vest on October 25, 2019 and an additional 1/16th of the grant will vest quarterly thereafter. F3: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. |
Filing footnotes · ownership attribution and instrument terms
F1: The exercise price of the non-employee warrant is 19.71 Euros. The U.S. dollar equivalent of the exercise price is $22.45 using the European Central Bank rate as of October 24, 2018 (1.00 = $1.1389), the date that is one business day prior to the date on which the issuer's board of directors determined the exercise price of the non-employee warrants.
F2: One-fourth of the grant will vest on October 25, 2019 and an additional 1/16th of the grant will vest quarterly thereafter.
F3: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
F4: The subscription price of the non-employee warrant is $7.87. The subscription price was satisfied by offset from fees otherwise paid to the reporting person by the issuer for service as a director.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 08, 2018 Filed Nov 13, 2018 16:15 UTC | Criteo S.A. CRTO · Entity 291 | GrantNon-employee Warrant (right to buy) · Derivative | 25,000 | $7.87 Strike: $22.45 | $196,750.00 |
DisclosureSEC source: 0001576427-18-000088 · wf-form4_154214368803306.xml · derivative · entry 1 Spielman Sharon Fox · CIK 0001669184 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Ordinary Shares · 25,000 shares Expires 2028-10-25 F1 · derivative.exercise_price: The exercise price of the non-employee warrant is 19.71 Euros. The U.S. dollar equivalent of the exercise price is $22.45 using the European Central Bank rate as of October 24, 2018 (1.00 = $1.1389), the date that is one business day prior to the date on which the issuer's board of directors determined the exercise price of the non-employee warrants. F4 · price: The subscription price of the non-employee warrant is $7.87. The subscription price was satisfied by offset from fees otherwise paid to the reporting person by the issuer for service as a director. F2 · derivative.exercise_date: One-fourth of the grant will vest on October 25, 2019 and an additional 1/16th of the grant will vest quarterly thereafter. F3 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
| October 26, 2017 Filed Oct 30, 2017 16:30 UTC | Criteo S.A. CRTO · Entity 291 | GrantNon-employee Warrant (right to buy) · Derivative | 12,225 | $16.36 Strike: $42.19 | $200,001.00 |
DisclosureSEC source: 0001209191-17-058306 · doc4.xml · derivative · entry 1 Spielman Sharon Fox · CIK 0001669184 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,225 Underlying: Ordinary Shares · 12,225 shares Expires 2027-10-26 F1 · derivative.exercise_price: The exercise price of the non-employee warrant is 35.80 euros. The U.S. dollar equivalent of the exercise price is $42.19 using the European Central Bank rate as of October 25, 2017 (1.00 = $1.1785). F4 · price: The subscription price of the non-employee warrant is 13.88 euros. The U.S. dollar equivalent of the exercise price is $16.36 using the European Central Bank rate as of October 25, 2017 (1.00 = $1.1785). The subscription price was satisfied by offset from fees otherwise payable to the reporting person by the Company for service as a director. F2 · derivative.exercise_date: One-fourth of the grant will vest on the first anniversary of the grant date and an additional 1/16th of the grant vests quarterly thereafter. F3 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.